°µÍø³Ô¹Ï
Main navigation
°µÍø³Ô¹Ï
°µÍø³Ô¹Ï
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Read more
about DecipheraPharmaceuticalsInc-2020-02-13
$201.3 Million
Image
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about ArrowheadPharmaceuticalsInc-2019-12-03
$266.8 Million
Image
Arrowhead Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about CRISPRTherapeuticsAG-2019-11-20
$315.2 Million
Image
CRISPR Therapeutics AG
Follow-On Offering
Active Bookrunner
Read more
about NextCureInc-2019-11-14
$172.3 Million
Image
NextCure, Inc.
Follow-On Offering
Active Bookrunner
Read more
about NateraInc-2019-10-16
$230.0 Million
Image
Natera, Inc.
Follow-On Offering
Active Bookrunner
Read more
about DecipheraPharmaceuticalsInc-2019-08-19
$460.0 Million
Image
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about BiohavenPharmaceuticalHoldingCompanyLtd-2019-06-18
$322.6 Million
Image
Biohaven Pharmaceutical Holding Company Ltd.
Follow-On Offering
Active Bookrunner
Read more
about ASLANPharmaceuticalsPteLtd-2021-03-02
$69.0 Million
Image
ASLAN Pharmaceuticals Pte. Ltd.
Follow-On Offering
Active Bookrunner
Read more
about BiohavenPharmaceuticalHoldingCompanyLtd-2018-12-12
$125.0 Million
Image
Biohaven Pharmaceutical Holding Company Ltd.
Follow-On Offering
Active Bookrunner
Read more
about RevanceTherapeuticsInc-2019-01-16
$115.0 Million
Image
Revance Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹â¶Ä¹
Page 26
Next page
›â¶Äº
Subscribe to Active Bookrunner
